These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33616911)

  • 1. Association of beta-hydroxybutyrate with development of heart failure: Sex differences in a Dutch population cohort.
    Flores-Guerrero JL; Westenbrink BD; Connelly MA; Otvos JD; Groothof D; Shalaurova I; Garcia E; Navis G; de Boer RA; Bakker SJL; Dullaart RPF
    Eur J Clin Invest; 2021 May; 51(5):e13468. PubMed ID: 33616911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating 3-hydroxy butyrate predicts mortality in patients with chronic heart failure with reduced ejection fraction.
    Christensen KH; Nielsen RR; Schou M; Gustafsson I; Jorsal A; Flyvbjerg A; Tarnow L; Bøtker HE; Kistorp C; Johannsen M; Møller N; Wiggers H
    ESC Heart Fail; 2024 Apr; 11(2):837-845. PubMed ID: 38196294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periodontal Status, C-Reactive Protein, NT-proBNP, and Incident Heart Failure: The ARIC Study.
    Molinsky RL; Yuzefpolskaya M; Norby FL; Yu B; Shah AM; Pankow JS; Ndumele CE; Lutsey PL; Papapanou PN; Beck JD; Colombo PC; Demmer RT
    JACC Heart Fail; 2022 Oct; 10(10):731-741. PubMed ID: 36175058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
    Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF.
    Savji N; Meijers WC; Bartz TM; Bhambhani V; Cushman M; Nayor M; Kizer JR; Sarma A; Blaha MJ; Gansevoort RT; Gardin JM; Hillege HL; Ji F; Kop WJ; Lau ES; Lee DS; Sadreyev R; van Gilst WH; Wang TJ; Zanni MV; Vasan RS; Allen NB; Psaty BM; van der Harst P; Levy D; Larson M; Shah SJ; de Boer RA; Gottdiener JS; Ho JE
    JACC Heart Fail; 2018 Aug; 6(8):701-709. PubMed ID: 30007554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium.
    Magnussen C; Niiranen TJ; Ojeda FM; Gianfagna F; Blankenberg S; Vartiainen E; Sans S; Pasterkamp G; Hughes M; Costanzo S; Donati MB; Jousilahti P; Linneberg A; Palosaari T; de Gaetano G; Bobak M; den Ruijter HM; Jørgensen T; Söderberg S; Kuulasmaa K; Zeller T; Iacoviello L; Salomaa V; Schnabel RB;
    JACC Heart Fail; 2019 Mar; 7(3):204-213. PubMed ID: 30819375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study.
    Binnenmars SH; Hoogslag GE; Yeung SMH; Brouwers FP; Bakker SJL; van Gilst WH; Gansevoort RT; Navis G; Voors AA; de Borst MH
    J Am Heart Assoc; 2022 Aug; 11(15):e024952. PubMed ID: 35876420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.
    Nielsen R; Møller N; Gormsen LC; Tolbod LP; Hansson NH; Sorensen J; Harms HJ; Frøkiær J; Eiskjaer H; Jespersen NR; Mellemkjaer S; Lassen TR; Pryds K; Bøtker HE; Wiggers H
    Circulation; 2019 Apr; 139(18):2129-2141. PubMed ID: 30884964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
    Brouwers FP; de Boer RA; van der Harst P; Voors AA; Gansevoort RT; Bakker SJ; Hillege HL; van Veldhuisen DJ; van Gilst WH
    Eur Heart J; 2013 May; 34(19):1424-31. PubMed ID: 23470495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
    Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
    Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
    Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study.
    Freiberg MS; Chang CH; Skanderson M; Patterson OV; DuVall SL; Brandt CA; So-Armah KA; Vasan RS; Oursler KA; Gottdiener J; Gottlieb S; Leaf D; Rodriguez-Barradas M; Tracy RP; Gibert CL; Rimland D; Bedimo RJ; Brown ST; Goetz MB; Warner A; Crothers K; Tindle HA; Alcorn C; Bachmann JM; Justice AC; Butt AA
    JAMA Cardiol; 2017 May; 2(5):536-546. PubMed ID: 28384660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study.
    Lam CSP; Gamble GD; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Cameron VA; Poppe K; Lund M; Devlin G; Troughton R; Richards AM; Doughty RN
    Eur Heart J; 2018 May; 39(20):1770-1780. PubMed ID: 29390051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
    Salah K; Stienen S; Pinto YM; Eurlings LW; Metra M; Bayes-Genis A; Verdiani V; Tijssen JGP; Kok WE
    Heart; 2019 Aug; 105(15):1182-1189. PubMed ID: 30962192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
    Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
    Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF.
    Savarese G; Orsini N; Hage C; Vedin O; Cosentino F; Rosano GMC; Dahlström U; Lund LH
    JACC Heart Fail; 2018 Mar; 6(3):246-256. PubMed ID: 29428439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction.
    Savarese G; Orsini N; Hage C; Dahlström U; Vedin O; Rosano GMC; Lund LH
    J Card Fail; 2018 Jun; 24(6):365-374. PubMed ID: 29597053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction.
    de Boer RA; Nayor M; deFilippi CR; Enserro D; Bhambhani V; Kizer JR; Blaha MJ; Brouwers FP; Cushman M; Lima JAC; Bahrami H; van der Harst P; Wang TJ; Gansevoort RT; Fox CS; Gaggin HK; Kop WJ; Liu K; Vasan RS; Psaty BM; Lee DS; Hillege HL; Bartz TM; Benjamin EJ; Chan C; Allison M; Gardin JM; Januzzi JL; Shah SJ; Levy D; Herrington DM; Larson MG; van Gilst WH; Gottdiener JS; Bertoni AG; Ho JE
    JAMA Cardiol; 2018 Mar; 3(3):215-224. PubMed ID: 29322198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-B-type natriuretic peptide in chronic heart failure: The impact of sex across the ejection fraction spectrum.
    Faxén UL; Lund LH; Orsini N; Strömberg A; Andersson DC; Linde C; Dahlström U; Savarese G
    Int J Cardiol; 2019 Jul; 287():66-72. PubMed ID: 31005415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
    Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
    JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.